CN112795587A - Escherichia coli engineering bacterium for producing surfactin and construction method and application thereof - Google Patents

Escherichia coli engineering bacterium for producing surfactin and construction method and application thereof Download PDF

Info

Publication number
CN112795587A
CN112795587A CN202110137604.0A CN202110137604A CN112795587A CN 112795587 A CN112795587 A CN 112795587A CN 202110137604 A CN202110137604 A CN 202110137604A CN 112795587 A CN112795587 A CN 112795587A
Authority
CN
China
Prior art keywords
srf
pwg
escherichia coli
surfactin
ccdb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110137604.0A
Other languages
Chinese (zh)
Other versions
CN112795587B (en
Inventor
魏韬
郭玉婧
邹苑
林俊芳
郑倩望
叶志伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Agricultural University
Original Assignee
South China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Agricultural University filed Critical South China Agricultural University
Priority to CN202110137604.0A priority Critical patent/CN112795587B/en
Publication of CN112795587A publication Critical patent/CN112795587A/en
Application granted granted Critical
Publication of CN112795587B publication Critical patent/CN112795587B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a colibacillus engineering bacterium for producing surfactin and a construction method and application thereof. The invention uses ExoCET recombination technology to transfer surfactant synthetic gene cluster and carrier segment with homologous arm obtained by double enzyme digestion into strain with recombination system after T4DNA polymerase annealing in vitro, to complete recombination, to obtain recombinant plasmid pWG-SRF. Transferring into Escherichia coli wild strain to obtain engineering bacteria BW 25113/pWG-SRF. The engineering strain has a more concise surfactin anabolic network constructed de novo, a smaller genome and a shorter fermentation growth period. In addition, the surfactant extracted from the escherichia coli strain fermentation liquor has a strong surfactant function, is expected to be developed and utilized in the fields of petroleum extraction, daily chemical industry, antibacterial and antiviral preparations and the like, and has a good development and utilization prospect.

Description

Escherichia coli engineering bacterium for producing surfactin and construction method and application thereof
Technical Field
The invention belongs to the field of microbial metabolic engineering and synthetic biology, and particularly relates to an escherichia coli engineering bacterium for producing surfactin, a construction method and application thereof, in particular to an engineering bacterium BW25113/pWG-SRF capable of producing surfactin.
Background
The surfactant is formed by condensing 7 amino acids and a beta hydroxy fatty acid chain (C12-C16), and is a cyclic lipopeptide mainly synthesized by bacillus bacteria [1 ]. The surfactant has extremely strong surface activity efficiency, is considered to be the strongest known biosurfactant at present, and has great application value in the aspects of petroleum, daily chemicals, sterilization and the like.
A great deal of past researches adopt methods such as culture medium optimization, reactor redesign, industrial and agricultural waste fermentation and the like to improve the synthesis level of the surfactant and reduce the price of raw materials, but all methods fail to achieve sufficient results [2 ].
A great deal of research shows that surfactin anabolism related genes in most of bacillus bacteria are also related to macroscopic growth and reproduction traits such as biofilm and spore formation [3 ]. In genome sequencing studies of Siamese Bacillus JFL15, it was found that the synthesis rate of surfactin is regulated by global regulators such as AbrB 4, DegU 5, CodY 6, etc., and is generally controlled to a lower range, thereby coordinating with other growth conditions of bacteria [7 ]. Meanwhile, synthesis of surfactin is also regulated by the quorum sensing system associated with sporulation such as ComXQPA [8 ].
When bacillus bacteria are used for fermenting and synthesizing surfactin, various cyclic lipopeptides and linear lipopeptides such as iturin (iturin) and fengycin (fengycin) can be simultaneously synthesized. Wherein, the three cyclic lipopeptides have similar structures and larger separation difficulty, and the production cost of the single-component surfactant is increased. Coutte et al report that the cost of separation and purification of currently marketed lipopeptide antibacterial peptide compounds accounts for more than 60% of the total production cost [9 ]. The separation of antibacterial substances from Siamese bacillus identifies 3 kinds of antibacterial lipopeptide compounds, siderophin compounds, polyketide compounds, cyclic dipeptide compounds and other antibacterial substances, and the complexity of the antibacterial lipopeptide kinds produced by bacillus bacteria is consistent with that reported in the past [10 ]. On the other hand, 2 structural analogues of iturin and fengycin were knocked out from Bacillus amyloliquefaciens NK-delta LP strains by Zhouyu et al, but synthesis of all kinds of antibacterial lipopeptides except for surfactin could not be completely prevented [11], suggesting that it is difficult to construct engineering bacteria of Bacillus for producing single-component surfactin.
In Bacillus, surfactin is synthesized by a multifunctional enzyme system (NRPS). The gene cluster for the synthesis of surfactin is the srf operon, which is 26kb in length [1 ].
Zhang Yogming et al reported that ExoCET recombination technology combines in vitro DNA recombination with in vivo RecET homologous recombination for the direct cloning of large fragment biosynthetic gene clusters. DNA fragments of sizes within 106kb were directly captured into expression vectors [12 ]. By using the above recombinant system, Zyoming et al successfully expressed 10 NRPS pathways in E.coli, of which 3 successfully detected the product [12 ]. Therefore, the successful construction of engineering bacteria for producing the single-component surfactant is of great significance.
Reference documents:
1. extreme metabolism mechanism and function research of efficient synthesis of surfactin by Bacillus [ D ] Jiangnan university, 2017.
2.Hamoen LW,Venema G,Kuipers OP.Controlling competence in Bacillus subtilis:shared use of regulators[J].Microbiology,2003.149(1):9-17.
3.Xu BH,Ye ZW,Zheng QW,et al.Isolation and characterization of cyclic lipopeptides withbroad-spectrum antimicrobial activity from Bacillus siamensis JFL15[J].3Biotech,2018.8(10):p.444-453.
4.Strauch MA,Bobay BG,Cavanagh J,et al.Abh and AbrB control of Bacillus subtilis antimicrobial gene expression[J].Journal of Bacteriology,2007.189(21):7720-7732.
5.Mitsuo O,Hirotake Y,Ken-Ichi Y,et al.DNA microarray analysis of Bacillus subtilis DegU,ComA and PhoP regulons:an approach to comprehensive analysis of B.subtilis two-component regulatory systems[J].Nucleic Acids Research,2001.29(18):3804-3813.
6.Serror P,Sonenshein AL.CodY is required for nutritional repression of Bacillus subtilis genetic competence[J].Journal of Bacteriology,1996.178(20):5910-5915.
7.Shaligram NS,Singhal RS.Surfactin--a review on biosynthesis,fermentation,purification and applications[J].Food Technology&Biotechnology,2010.48(2):119-134.
8.Oslizlo A,Stefanic P,Vatovec S,et al.Exploring ComQXPA quorum-sensing diversity and biocontrol potential of Bacillus spp.isolates from tomato rhizoplane[J].Microbial Biotechnology,2015.8(3):527-540.
9.Coutte F,Lecouturier D,Dimitrov K,et al.Microbial lipopeptide production and purification bioprocesses,current progress and future challenges[J].Biotechnology Journal,2017.12(7):1600566.
10.Xu BH,Lu YQ,Ye ZW,et al.Genomics-guided discovery and structure identification of cyclic lipopeptides from the Bacillus siamensis JFL15[J].PloS one,2018.13(8):e0202893-e0202893.
11. Zhouyu, Zhang Wan Ru, Zhang Dang Xuan Hemerocallis, and the like, the metabolic engineering transformation of Bacillus amyloliquefaciens improves the yield of Surfactin [ J ]. the university report of south China: nature science edition 2018.51(5):18-26.
12.Fu J,Bian X,Hu S,et al.Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting[J].Nature Biotechnology,2012.30:440-446.
Disclosure of Invention
In order to overcome the defects of various structural analogs and complex molecular regulation mechanism of a surfactin fermenting and synthesizing strain in the prior art, the invention aims to provide a construction method of escherichia coli engineering bacteria for producing surfactin.
The invention also aims to provide the escherichia coli engineering bacteria for producing the surfactant, which are obtained by the construction method.
The invention also aims to provide application of the escherichia coli engineering bacteria.
According to the invention, by an ExoCET recombination technology, a surfactant synthetic gene cluster and a vector fragment with a homologous arm obtained by double enzyme digestion are annealed by T4DNA polymerase in vitro and then transferred into a strain with a recombination system to complete recombination, so that a recombinant plasmid pWG-SRF is obtained. Extracting expression vector DNA connected with surfactant synthetic gene cluster, transferring into Escherichia coli wild strain, and obtaining engineering bacteria BW 25113/pWG-SRF. And (3) shaking the flask to ferment the engineering bacteria, measuring the surfactant content of the engineering bacteria by using an HPLC method, and measuring the activity of a crude extract of fermentation liquor according to an oil discharge ring method.
The purpose of the invention is realized by the following technical scheme:
a construction method of colibacillus engineering bacteria for producing surfactin comprises the following steps:
(1) analyzing a Siamese bacillus JFL15 genome, and comparing the genome with an NCBI database to obtain a surfactant synthetic gene cluster sequence;
(2) carrying out double enzyme digestion on genome DNA of Siamese bacillus JFL15 by KpnI/BamHI to obtain surfactin synthetic gene cluster DNA;
(3) carrying out T4DNA polymerase annealing on surfactant synthetic gene cluster DNA obtained by double enzyme digestion and p15A-Cm-HA in vitro by using an ExoCET method, transferring the DNA into a GB05-dir strain with a recombination system for recombination to obtain an engineering bacterium, and marking the engineering bacterium as GB 05-dir/pWG-SRF; the sequence of the p15A-Cm-HA is shown in SEQ ID NO: 1 is shown in the specification;
(4) extracting plasmid pWG-SRF from GB05-dir/pWG-SRF, transforming plasmid pWG-SRF into Escherichia coli wild strain BW25113, and obtaining engineering bacteria BW 25113/pWG-SRF.
In the step (1), the genome of Siamese Bacillus JFL15 is analyzed by using anti SMASH.
In the step (2), the fragment size of the surfactant synthetic gene cluster DNA is 32539 bp.
In the step (3), preferably, the GB05-dir strain with the recombination system is a GB05-dir strain with pSC101-BAD-ETgA-tet, and is marked as GB05-dir/pSC 101-BAD-ETgA-tet;
in step (3), preferably, the p15A-Cm-HA is constructed by the following steps:
counting 80bp from restriction enzyme sites KpnI and BamHI of a Siamese bacillus JFL15 genome to the inside of a gene cluster to be used as homology arms, designing a primer pair p15ACm F/p15ACm R, and amplifying a fragment with the 80bp homology arms by using pBAD-p15A-Cm-ccdB as a template, wherein the fragment is marked as p 15A-Cm-HA;
p15ACm F:5'-tcataaaatttcattaattgtcattgtagcataaacgccgaaaaaaagaagaagcgaaatcagtgtttcgcttcttctccggatccATGCGAGAGTAGGGAACTGC-3'; the crosshatched portion is the BamHI cleavage site.
p15ACm R:5'-gaggctgacggagctgtttcatttgaagcaaggagaaatacgaaggcatttattgtcctcaggcttaatacaaatgaaccggtaccATCTGATTAATAAGATGATC-3'; the underlined part represents a KpnI cleavage site.
Wherein the lower case part is a homology arm.
Preferably, the pBAD-p15A-Cm-ccdB is constructed by the following steps:
the vector pBAD33 is used as a template, p15A F/p15A R and Cm F/Cm R are used as primers, and pBAD-p15A with the size of 2070bp and Cm with the size of 1215bp are amplified; amplifying a 371bp ccdB gene fragment by using a plasmid pMD-ccdBKanS as a template and ccdB F/ccdB R as a primer, and assembling the 371bp ccdB gene fragment by using a TEDA one-step method to obtain a pBAD-p15A-Cm-ccdB plasmid;
p15A F:5'-AGTGAGAGGGCCGCGGCAAAG-3';
p15A R:5'-GGTACCGAGCTCGAATTCGC-3';
Cm F:5'-gccgcggccctctcactGCGAAAATGAGACGTTGATC-3';
Cm R:5'-AAGCTTGGCTGTTTTGGCGG-3';
ccdB F:5'-gcgaattcgagctcggtaccTTTCGGAATTAAGGAGGTAA-3';
ccdB R:5'-ccgccaaaacagccaagcttTTATATTCCCCAGAACATCA-3';
wherein the lower case part is a homology arm.
An escherichia coli engineering bacterium for producing surfactin is constructed by the construction method.
Fermenting the engineering bacteria of escherichia coli, extracting active substances to obtain a crude extract of fermentation liquor, and detecting by using a high performance liquid chromatography and an oil discharge ring method.
A recombinant expression vector pWG-SRF is constructed by the construction method.
The colibacillus engineering bacteria for producing the surfactin is applied to fermentation production of the surfactin.
The crude extract of fermentation liquor of escherichia coli engineering bacteria for producing surfactin can be applied to the fields of petroleum extraction, daily chemical industry, antibacterial and antiviral preparations and the like.
Compared with the prior art, the invention has the following advantages and effects:
the invention provides an escherichia coli engineering bacterium BW25113/pWG-SRF for producing surfactin, which is obtained by heterologous synthesis through a genetic engineering means and has the characteristics of simple culture, high growth speed and the like. Compared with the starting bacterium Siamese bacillus JFL15, the strain has a more concise surfactin anabolism network constructed de novo, a smaller genome and a shorter fermentation growth period. In addition, Escherichia coli does not produce surfactin structural analogs, and thus separation and purification costs are expected to be reduced. The surfactant extracted from the escherichia coli strain fermentation liquor has a strong surfactant function, is expected to be developed and utilized in the fields of petroleum extraction, daily chemical industry, antibacterial and antiviral preparations and the like, and has a good development and utilization prospect.
Drawings
FIG. 1 shows the EcoRI cleavage identification result of the vector pBAD-p 15A-Cm-ccdB; wherein, M: 1kb ladder DNA Maker; 1. 2, 3, 4: and (4) enzyme digestion to identify a correct transformant.
FIG. 2 shows the BglII cleavage identification result of pWG-SRF; wherein, M: 1kb ladder DNA Maker; 1. 2: BglII cleavage identified the correct transformants.
FIG. 3 shows the results of the restriction enzyme digestion of pWG-SRF with EcoRI, wherein M: 1kb ladder DNA Maker; 1. 2: EcoRI digestion identified the correct transformants.
FIG. 4 shows the results of measuring the content of surfactin in the fermentation broth of engineering bacteria BW25113/pWG-SRF by high performance liquid chromatography; wherein, 1: a surfactant standard (sigma standard); siemens JFL 15; 3: BW25113/pBAD 33; 4: BW 25113/pWG-SRF; the ordinate of 2 was spaced at 100mV intervals, the remainder at 10 mV.
FIG. 5 shows the results of the oil drainage test for crude fermentation broth; siemensis JFL 15; 2: BW25113/pBAD 33; 3: BW 25113/pWG-SRF.
Detailed Description
The present invention will be described in further detail with reference to examples and drawings, but the present invention is not limited thereto.
The test methods in the following examples, in which specific experimental conditions are not specified, are generally performed according to conventional experimental conditions or according to the experimental conditions recommended by the manufacturer. The materials, reagents and the like used are, unless otherwise specified, reagents and materials obtained from commercial sources.
The biomaterial used in the examples of the invention is as follows:
siamese Bacillus (Bacillus siamensis) JFL15 is disclosed in 201811086453.5, a method for transforming Siamese Bacillus by electric shock.
Coli BW25113 strain, pBAD33 vector, lysozyme and proteinase K were all commercially available.
pMD-ccdBKanS is disclosed in "Wei T, et al," Genome engineering Escherichia coli for L-DOPA over production from glucose.2016.6: p.30080 ".
GB05-dir/pSC101-BAD-ETgA-tet is obtained by transforming pSC101-BAD-ETgA-tet into E.coli GB05-dir, wherein E.coli GB05-dir and pSC101-BAD-ETgA-tet are disclosed in the literature "Wang H, et al, Exocet: exogenous enzyme in vitro assembly with RecET combining for high efficiency functional direct DNA cloning from complex genes, 2017.46(5): p.e28.";
TEDA one-step, multi-fragment assembly is disclosed in "Xia Y, et al, T5 exonuclease-dependent assembly of reagents a low-cost method for influencing and site-directed mutagenesis, nucleic Acids Res,2019.47(3): p.e 15.";
ExoCET large fragment cloning techniques are disclosed in "Wang, H., et al," ExoCET: exoenzyme in vitro assembly with RecET assembly for high throughput direct DNA cloning from complex genes, nucleic Acids Research,2017.46(5): p.e28.
EXAMPLE 1 cloning of surfactant Synthesis Gene Cluster
The vector pBAD33 is used as a template, p15A F/p15A R and Cm F/Cm R are used as primers, PrimeSTAR Max DNA Polymerase (Takara) is used for amplifying pBAD-p15A with 2070bp and Cm (chloramphenicol) with 1215bp, plasmid pMD-ccdBKanS is used as a template, ccdB F/ccdB R is used as a primer for amplifying 371bp ccdB, TEDA one-step method is used for multi-fragment assembly, after a transformant is obtained, enzyme digestion identification is carried out, and the pBAD-p15A-Cm-ccdB plasmid with 3599bp is obtained. The enzyme digestion identification is shown in figure 1, the EcoRI is used for carrying out enzyme digestion verification on the pBAD-p15A-Cm-ccdB, and 1210bp and 2389bp bands are cut out by the EcoRI, which indicates that the plasmid pBAD-p15A-Cm-ccdB is successfully constructed.
p15A F:5'-AGTGAGAGGGCCGCGGCAAAG-3';
p15A R:5'-GGTACCGAGCTCGAATTCGC-3';
Cm F:5'-gccgcggccctctcactGCGAAAATGAGACGTTGATC-3';
Cm R:5'-AAGCTTGGCTGTTTTGGCGG-3';
ccdB F:5'-gcgaattcgagctcggtaccTTTCGGAATTAAGGAGGTAA-3';
ccdB R:5'-ccgccaaaacagccaagcttTTATATTCCCCAGAACATCA-3';
Wherein the lower case part is a homology arm.
Analyzing a Siamese bacillus JFL15 genome by using anti SMASH, and comparing the genome with an NCBI database to obtain a surfactant synthetic gene cluster sequence; among these, the whole genome sequence of the siamese bacillus JFL15 genome has been published at NCBI with GenBank accession number LFWQ 00000000.1. The surfactant synthesis gene cluster sequence has the position 1904569-1937107 in LFWQ 00000000.1.
A primer pair p15ACm F/p15ACm R is designed by taking 80bp from the restriction enzyme sites KpnI and BamHI of a Siamese Bacillus JFL15 genome to the inside of a gene cluster as homology arms, a fragment with 80bp homology arms is amplified by using PrimeSTAR Max DNA Polymerase (Takara) and pBAD-p15A-Cm-ccdB as a template, the size of the fragment is 1784bp and is marked as p15A-Cm-HA (the sequence of the fragment is shown as SEQ ID NO: 1), and the gel is cut and recovered according to the operation of a gel recovery kit.
p15ACm F:5'-tcataaaatttcattaattgtcattgtagcataaacgccgaaaaaaagaagaagcgaaatcagtgtttcgcttcttctccggatccATGCGAGAGTAGGGAACTGC-3'; the crosshatched portion is the BamHI cleavage site.
p15ACm R:5'-gaggctgacggagctgtttcatttgaagcaaggagaaatacgaaggcatttattgtcctcaggcttaatacaaatgaaccggtaccATCTGATTAATAAGATGATC-3'; the underlined part represents a KpnI cleavage site.
Wherein the lower case part is a homology arm.
Overnight cultured Siamese bacillus JFL15 thalli were collected. Cells were washed once with ultrapure water. 8mL of SET (75mM NaCl, 25mM EDTA, 20mM Tris, pH 8.0), 40mg of lysozyme were added in a water bath at 37 ℃ for 2 hours. 20mg of proteinase K, 1mL of 10% SDS and water bath at 50 ℃ for 4-5 hours until the mixture is clear. 3.5mL of 5M NaCl was added. The genomic DNA was extracted by phenol-chloroform-isoamyl alcohol (25:24:1) extraction, absolute ethanol precipitation, and finally dissolved in 300. mu.L of 10mM Tris-HCl (pH 8.0).
50 mu g of genome DNA is cut by KpnI/BamHI enzyme, and 400 mu L of the system is cut by enzyme at 37 ℃ for 1h to obtain the surfactant synthetic gene cluster DNA, and the fragment size is 32539 bp.
Enzyme digestion system:
Figure BDA0002927619130000071
the genomic DNA double-digested with KpnI/BamHI was extracted by phenol-chloroform-isoamyl alcohol (25:24:1) extraction and precipitated with absolute ethanol, and finally dissolved in 12. mu.L of ddH2O, taking 2 mu L of agarose gel with the concentration of 1 percentAnd (5) carrying out electrophoresis detection. The results indicate that the restriction enzyme will cut the genomic DNA apart, thereby successfully obtaining the surfactant synthesis gene cluster.
mu.L of 1. mu.g/. mu.L of genomic DNA double-digested with KpnI/BamHI, 1. mu.L of 200 ng/. mu. L p 15-15A-Cm-HA, 2. mu.L of 10 XNEB Buffer 2.1, 0.13. mu.L of 3U/. mu. L T4DNA polymerase and 6.87. mu.L of ddH2O mixed into a 20. mu.L reaction system. Treating the reaction system according to the reaction steps of 25 ℃ for 60min, 75 ℃ for 25min and 50 ℃ for 30min, cooling to 4 ℃ after the reaction is finished, stopping the reaction, and desalting at room temperature for 30min to obtain desalted reaction liquid.
By using an ExoCET method, recombining the surfactant synthetic gene cluster DNA obtained by enzyme digestion and a p15A-Cm-HA carrier fragment in a GB05-dir strain (engineering bacteria GB05-dir/pSC101-BAD-ETgA-tet) with a recombination system to obtain the engineering bacteria GB 05-dir/pWG-SRF; the method comprises the following specific steps:
40 mu L of engineering bacteria GB05-dir/pSC101-BAD-ETgA-tet (OD)6003-4) was inoculated into 1.4mL of LB liquid medium. After shaking culture at 30 ℃ and 200rpm for 2h, the OD is waited600Adding 35 mu L of 10% L-arabinose when the value reaches 0.35-0.4, and continuing culturing at 37 ℃ for 40min to OD6000.7 to 0.8. Transferring the bacterial liquid to ice bath treatment at 2 deg.c to terminate the growth of thallus, and centrifuging at 8000rpm to collect thallus. With ice-cold 1mL ddH2The cells were O-washed 2 times. Resuspended in 20. mu.L of ice-cold ddH2O, 8. mu.L of the desalted reaction solution was added thereto and mixed. After the transformation by electric shock in an electric shock cup with the width of a liquid adding gap of 1mm, 1mL of LB liquid culture medium is added, and the mixture is subjected to oscillatory recovery culture at 37 ℃ and 200rpm for 1-2 h. After the completion of the recovery culture, centrifugation is carried out for 2min at 8000rpm, after partial supernatant is removed, the heavy suspension liquid is blown out and coated on an LB (Cm +) plate, and inversion culture is carried out overnight at 37 ℃. The next day, colony PCR preliminary identification was performed. The bacterial strain correctly identified by colony PCR is marked as GB 05-dir/pWG-SRF; further extracting a plasmid, marked as pWG-SRF, and carrying out enzyme digestion identification.
Example 2 enzyme cleavage identification
Plasmid pWG-SRF, size 34151bp, including surfactant synthesis gene cluster DNA fragment (size 32539bp) and p15A-Cm-HA (size 1784bp) with 80bp homology arm.
The DNA was cleaved with BglII, which has 8 cleavage sites at pWG-SRF, and EcoRI, respectively. The 8739bp, 6997bp, 5549bp, 5158bp, 2803bp, 2040bp, 1950bp and 915bp 8 bands are cut out. EcoRI has 7 cleavage sites at pWG-SRF. 7 bands of 12805bp, 8357bp, 3650bp, 3289bp, 3263bp, 1992bp and 795bp are cut out. After the system is prepared, the enzyme is cut for 30min at 37 ℃, and 10 mu L of the enzyme is detected by 1 percent agarose gel electrophoresis. As shown in FIGS. 2 and 3, the band 8739bp, 6997bp, 5549bp, 5158bp, 2803bp, 2040bp, 1950bp, 915bp 8 was excised from Bgl II; the 2040bp and 1950bp bands are not separated during electrophoresis. Cutting 7 bands of 12805bp, 8357bp, 3650bp, 3289bp, 3263bp, 1992bp and 795bp by EcoRI; the two bands of 3289bp and 3263bp are not separated during electrophoresis. Thus, the construction of the plasmid pWG-SRF is successful.
Enzyme digestion system:
Figure BDA0002927619130000091
example 3 engineering bacteria obtention
Extracting plasmid pWG-SRF, and electrically transferring plasmid pWG-SRF into E.coli BW25113 competent cells to obtain engineering bacteria BW 25113/pWG-SRF.
Example 4 fermentation extraction of surfactin
The fermentation medium is low-salt LB: 1% peptone; 0.5% yeast extract; 0.1% NaCl, pH 7.0. The seed solution was transferred to the fermentation medium (50mL/250mL) at 1% inoculum size, Cm was added at a final concentration of 15 μ g/mL, 30 ℃, 200rpm, 3 bottles were inoculated with each bacterium (engineering bacteria BW25113/pWG-SRF, positive control Bacillus siamensis JFL15, negative control BW25113/pBAD33) as three replicates, and the compound was co-fermented for 72h, wherein 1mL XAD 16 macroporous adsorbent resin (commercially available as usual) was added at 48h of fermentation. The resin-added 50mL of the bacterial solution was transferred to a 50mL centrifuge tube, centrifuged at 8000rpm for 15min, and the supernatant was discarded. Adding 30mL of methanol into the precipitate, carrying out ultrasonic resuspension, pouring into the original triangular flask, and shaking at 30 ℃ and 180rpm for 3 hours. The cells and resin in the flask were poured into a new 50mL centrifuge tube and centrifuged at 8000rpm for 15 min. The supernatant was filtered through filter paper into a 100mL conical flask, which was evaporated to dryness by a rotary evaporator, and the crude extract was dissolved in 1mL of methanol. 12000rpm, centrifugation for 10 min. Filtering the supernatant with filter head, transferring into centrifuge tube to obtain crude extract of fermentation liquid, and storing at-20 deg.C.
Example 5 surfactant detection method
Performing high performance liquid chromatography detection by using Shimadzu LC 2030 CN; the detector is an ultraviolet detector; chromatographic column ODS-SP (5.0 μm, 4.6X 250mm, GL Sciences); the ultraviolet detection wavelength is 205 nm; the column temperature is 30 ℃; the mobile phase was methanol/water (containing 0.1% trifluoroacetic acid) 90: 10; the flow rate is 1 mL/min; the amount of the sample was 10. mu.L.
The content of the surfactant in the fermentation liquor of the engineering bacteria BW25113/pWG-SRF is detected by using high performance liquid chromatography, and the result is shown in figure 4, the engineering bacteria BW25113/pWG-SRF can generate a peak consistent with a surfactant standard and a positive control B.siemensis JFL15 at 8.3min, and the negative control BW25113/pBAD33 has no peak. The engineering bacteria BW25113/pWG-SRF can produce the surfactant with higher purity. Solves the problem of difficult separation and purification caused by a plurality of structural analogs when the surface active element is produced by fermentation of bacillus.
Example 6 Activity test method of crude extract of fermentation broth of engineering bacteria
The oil discharge performance of the crude extract of the fermentation liquor is measured by adopting an oil discharge ring method, and the specific method comprises the following steps: taking 100 mu L of the crude extract of the fermentation liquid obtained in the example 4, naturally volatilizing, and redissolving in 100 mu L of ddH2And O. Add 50mL ddH to a 9cm diameter Petri dish2And O, dripping 200 mu L of Sudan III dyed olive oil on the water surface, after an oil layer is spread, slowly dripping 10 mu L of water-soluble crude extract of fermentation liquor into the center of the oil layer, and recording the result after an oil discharge ring is stable. The results are shown in FIG. 5, compared with positive control B.siemensis JFL15 and negative control BW25113/pBAD33, the crude extract of fermentation liquor of engineering bacteria BW25113/pWG-SRF can generate obvious oil drain circle. The engineering bacteria BW25113/pWG-SRF can produce the surfactant with higher purity.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Sequence listing
<110> southern China university of agriculture
<120> Escherichia coli engineering bacterium for producing surfactin, construction method and application thereof
<160> 9
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1784
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> p15A-Cm-HA
<400> 1
tcataaaatt tcattaattg tcattgtagc ataaacgccg aaaaaaagaa gaagcgaaat 60
cagtgtttcg cttcttctcc ggatccatgc gagagtaggg aactgccagg catcaaataa 120
aacgaaaggc tcagtcgaaa gactgggcct ttcgttttat ctgttgtttg tcggtgaacg 180
ctctcctgag taggacaaat ccgccgggag cggatttgaa cgttgcgaag caacggcccg 240
gagggtggcg ggcaggacgc ccgccataaa ctgccaggca tcaaattaag cagaaggcca 300
tcctgacgga tggccttttt ctagattacg ccccgccctg ccactcatcg cagtactgtt 360
gtaattcatt aagcattctg ccgacatgga agccatcaca gacggcatga tgaacctgaa 420
tcgccagcgg catcagcacc ttgtcgcctt gcgtataata tttgcccatg gtgaaaacgg 480
gggcgaagaa gttgtccata ttggccacgt ttaaatcaaa actggtgaaa ctcacccagg 540
gattggctga gacgaaaaac atattctcaa taaacccttt agggaaatag gccaggtttt 600
caccgtaaca cgccacatct tgcgaatata tgtgtagaaa ctgccggaaa tcgtcgtggt 660
attcactcca gagcgatgaa aacgtttcag tttgctcatg gaaaacggtg taacaagggt 720
gaacactatc ccatatcacc agctcaccgt ctttcattgc catacggaat tccggatgag 780
cattcatcag gcgggcaaga atgtgaataa aggccggata aaacttgtgc ttatttttct 840
ttacggtctt taaaaaggcc gtaatatcca gctgaacggt ctggttatag gtacattgag 900
caactgactg aaatgcctca aaatgttctt tacgatgcca ttgggatata tcaacggtgg 960
tatatccagt gatttttttc tccattttag cttccttagc tcctgaaaat ctcgataact 1020
caaaaaatac gcccggtagt gatcttattt cattatggtg aaagttggaa cctcttacgt 1080
gccgatcaac gtctcatttt cgcagtgaga gggccgcggc aaagccgttt ttccataggc 1140
tccgcccccc tgacaagcat cacgaaatct gacgctcaaa tcagtggtgg cgaaacccga 1200
caggactata aagataccag gcgtttcccc ctggcggctc cctcgtgcgc tctcctgttc 1260
ctgcctttcg gtttaccggt gtcattccgc tgttatggcc gcgtttgtct cattccacgc 1320
ctgacactca gttccgggta ggcagttcgc tccaagctgg actgtatgca cgaacccccc 1380
gttcagtccg accgctgcgc cttatccggt aactatcgtc ttgagtccaa cccggaaaga 1440
catgcaaaag caccactggc agcagccact ggtaattgat ttagaggagt tagtcttgaa 1500
gtcatgcgcc ggttaaggct aaactgaaag gacaagtttt ggtgactgcg ctcctccaag 1560
ccagttacct cggttcaaag agttggtagc tcagagaacc ttcgaaaaac cgccctgcaa 1620
ggcggttttt tcgttttcag agcaagagat tacgcgcaga ccaaaacgat ctcaagaaga 1680
tcatcttatt aatcagatgg taccggttca tttgtattaa gcctgaggac aataaatgcc 1740
ttcgtatttc tccttgcttc aaatgaaaca gctccgtcag cctc 1784
<210> 2
<211> 106
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> p15ACm F
<400> 2
tcataaaatt tcattaattg tcattgtagc ataaacgccg aaaaaaagaa gaagcgaaat 60
cagtgtttcg cttcttctcc ggatccatgc gagagtaggg aactgc 106
<210> 3
<211> 106
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> p15ACm R
<400> 3
gaggctgacg gagctgtttc atttgaagca aggagaaata cgaaggcatt tattgtcctc 60
aggcttaata caaatgaacc ggtaccatct gattaataag atgatc 106
<210> 4
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> p15A F
<400> 4
agtgagaggg ccgcggcaaa g 21
<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> p15A R
<400> 5
ggtaccgagc tcgaattcgc 20
<210> 6
<211> 37
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> Cm F
<400> 6
gccgcggccc tctcactgcg aaaatgagac gttgatc 37
<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> Cm R
<400> 7
aagcttggct gttttggcgg 20
<210> 8
<211> 40
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> ccdB F
<400> 8
gcgaattcga gctcggtacc tttcggaatt aaggaggtaa 40
<210> 9
<211> 40
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> ccdB R
<400> 9
ccgccaaaac agccaagctt ttatattccc cagaacatca 40

Claims (10)

1. A construction method of colibacillus engineering bacteria for producing surfactin is characterized by comprising the following steps:
(1) analyzing a Siamese bacillus JFL15 genome, and comparing the genome with an NCBI database to obtain a surfactant synthetic gene cluster sequence;
(2) carrying out double enzyme digestion on genome DNA of Siamese bacillus JFL15 by KpnI/BamHI to obtain surfactin synthetic gene cluster DNA;
(3) carrying out T4DNA polymerase annealing on surfactant synthetic gene cluster DNA obtained by double enzyme digestion and p15A-Cm-HA in vitro by using an ExoCET method, transferring the DNA into a GB05-dir strain with a recombination system for recombination to obtain an engineering bacterium, and marking the engineering bacterium as GB 05-dir/pWG-SRF; the sequence of the p15A-Cm-HA is shown in SEQ ID NO: 1 is shown in the specification;
(4) extracting plasmid pWG-SRF from GB05-dir/pWG-SRF, transforming plasmid pWG-SRF into Escherichia coli wild strain BW25113, and obtaining engineering bacteria BW 25113/pWG-SRF.
2. The method for constructing escherichia coli engineering bacteria producing surfactin as claimed in claim 1, wherein the method comprises the following steps:
in the step (1), the genome of Siamese Bacillus JFL15 is analyzed by using anti SMASH.
3. The method for constructing escherichia coli engineering bacteria producing surfactin as claimed in claim 1, wherein the method comprises the following steps:
in the step (2), the fragment size of the surfactant synthetic gene cluster DNA is 32539 bp.
4. The method for constructing escherichia coli engineering bacteria producing surfactin as claimed in claim 1, wherein the method comprises the following steps:
in the step (3), the GB05-dir strain with the recombination system is a GB05-dir strain with pSC101-BAD-ETgA-tet, and is marked as GB05-dir/pSC 101-BAD-ETgA-tet.
5. The method for constructing escherichia coli engineering bacteria producing surfactin as claimed in claim 1, wherein the method comprises the following steps:
in the step (3), the p15A-Cm-HA is constructed by the following steps:
counting 80bp from restriction enzyme sites KpnI and BamHI of a Siamese bacillus JFL15 genome to the inside of a gene cluster to be used as homology arms, designing a primer pair p15ACm F/p15ACm R, and amplifying a fragment with the 80bp homology arms by using pBAD-p15A-Cm-ccdB as a template, wherein the fragment is marked as p 15A-Cm-HA;
p15ACm F:5'-tcataaaatttcattaattgtcattgtagcataaacgccgaaaaaaagaagaagcgaaatcagtgtttcgcttcttctccggatccATGCGAGAGTAGGGAACTGC-3'; line segment for drawing transverse lineIs BamHI enzyme cutting site;
p15ACm R:5'-gaggctgacggagctgtttcatttgaagcaaggagaaatacgaaggcatttattgtcctcaggcttaatacaaatgaaccggtaccATCTGATTAATAAGATGATC-3'; the horizontal drawing part is KpnI restriction enzyme cutting site;
wherein, the lower case part is a homologous arm;
the pBAD-p15A-Cm-ccdB is constructed by the following steps:
the vector pBAD33 is used as a template, p15A F/p15A R and Cm F/Cm R are used as primers, and pBAD-p15A with the size of 2070bp and Cm with the size of 1215bp are amplified; amplifying a 371bp ccdB gene fragment by using a plasmid pMD-ccdBKanS as a template and ccdB F/ccdB R as a primer, and assembling the 371bp ccdB gene fragment by using a TEDA one-step method to obtain a pBAD-p15A-Cm-ccdB plasmid;
p15A F:5'-AGTGAGAGGGCCGCGGCAAAG-3';
p15A R:5'-GGTACCGAGCTCGAATTCGC-3';
Cm F:5'-gccgcggccctctcactGCGAAAATGAGACGTTGATC-3';
Cm R:5'-AAGCTTGGCTGTTTTGGCGG-3';
ccdB F:5'-gcgaattcgagctcggtaccTTTCGGAATTAAGGAGGTAA-3';
ccdB R:5'-ccgccaaaacagccaagcttTTATATTCCCCAGAACATCA-3';
wherein the lower case part is a homology arm.
6. An escherichia coli engineering bacterium producing surfactin, which is constructed by the construction method of any one of claims 1 to 5.
7. A recombinant expression vector pWG-SRF, comprising: the pWG-SRF is the pWG-SRF described in any one of the construction methods of claims 1 to 5.
8. The use of the escherichia coli engineered bacterium producing surfactin as claimed in claim 6 for fermentation production of surfactin.
9. The application of the crude extract of fermentation liquor of escherichia coli engineering bacteria producing surfactin as claimed in claim 6 in petroleum extraction, daily chemical industry, antibacterial and antiviral preparations.
10. Use according to claim 9, characterized in that:
the crude extract of fermentation liquor is obtained by fermenting the engineering bacteria of Escherichia coli as claimed in claim 6 and extracting active substances.
CN202110137604.0A 2021-02-01 2021-02-01 Escherichia coli engineering bacteria producing surfactant, construction method and application thereof Active CN112795587B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110137604.0A CN112795587B (en) 2021-02-01 2021-02-01 Escherichia coli engineering bacteria producing surfactant, construction method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110137604.0A CN112795587B (en) 2021-02-01 2021-02-01 Escherichia coli engineering bacteria producing surfactant, construction method and application thereof

Publications (2)

Publication Number Publication Date
CN112795587A true CN112795587A (en) 2021-05-14
CN112795587B CN112795587B (en) 2023-08-29

Family

ID=75813436

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110137604.0A Active CN112795587B (en) 2021-02-01 2021-02-01 Escherichia coli engineering bacteria producing surfactant, construction method and application thereof

Country Status (1)

Country Link
CN (1) CN112795587B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115109122A (en) * 2022-08-29 2022-09-27 华南农业大学 Rapid extraction method for extracting surfactin based on XAD16 macroporous resin

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0576050A1 (en) * 1992-04-24 1993-12-29 ENIRICERCHE S.p.A. Isolation and characterisation of the sfp gene of Bacillus subtilis
JP2007135533A (en) * 2005-11-22 2007-06-07 Mitsubishi Chemicals Corp Method for expressing gene in high efficiency
CN101240259A (en) * 2008-01-16 2008-08-13 南京工业大学 Novel constructed high-yield fumaric acid gene engineering bacterium and method for producing fumaric acid thereby
CN106754489A (en) * 2016-12-01 2017-05-31 华南农业大学 Methylotrophic bacillus F7 and its application
CN111004815A (en) * 2019-12-18 2020-04-14 江苏省农业科学院 Method for improving yield of surface active element of bacillus subtilis by mutating degU gene

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0576050A1 (en) * 1992-04-24 1993-12-29 ENIRICERCHE S.p.A. Isolation and characterisation of the sfp gene of Bacillus subtilis
JP2007135533A (en) * 2005-11-22 2007-06-07 Mitsubishi Chemicals Corp Method for expressing gene in high efficiency
CN101240259A (en) * 2008-01-16 2008-08-13 南京工业大学 Novel constructed high-yield fumaric acid gene engineering bacterium and method for producing fumaric acid thereby
CN106754489A (en) * 2016-12-01 2017-05-31 华南农业大学 Methylotrophic bacillus F7 and its application
CN111004815A (en) * 2019-12-18 2020-04-14 江苏省农业科学院 Method for improving yield of surface active element of bacillus subtilis by mutating degU gene

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
YEONG-HSIANG CHENG等: "Optimization of surfactin production from Bacillus subtilis in fermentation and its effects on Clostridium perfringens-induced necrotic enteritis and growth performance in broilers", 《JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION》 *
YEONG-HSIANG CHENG等: "Optimization of surfactin production from Bacillus subtilis in fermentation and its effects on Clostridium perfringens-induced necrotic enteritis and growth performance in broilers", 《JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION》, vol. 102, no. 05, 14 June 2018 (2018-06-14), pages 1232 - 1244 *
张铮等: "一株产表面活性剂细菌鉴定及发酵条件优化", 《工业微生物》 *
张铮等: "一株产表面活性剂细菌鉴定及发酵条件优化", 《工业微生物》, vol. 44, no. 06, 22 December 2014 (2014-12-22), pages 21 *
李俊峰等: "脂肽类生物表面活性剂的研究进展", 《化学与生物工程》 *
李俊峰等: "脂肽类生物表面活性剂的研究进展", 《化学与生物工程》, vol. 32, no. 01, 25 January 2015 (2015-01-25), pages 12 - 15 *
汪多仁编著: "《有机食品表面活性剂》", 30 April 2009, 科学技术文献出版社, pages: 178 - 179 *
潘旭耀等: "芽孢杆菌种间原生质体融合选育高产Surfactin新菌株", 《生物技术通报》 *
潘旭耀等: "芽孢杆菌种间原生质体融合选育高产Surfactin新菌株", 《生物技术通报》, vol. 35, no. 08, 26 August 2019 (2019-08-26), pages 238 - 245 *
许本宏: "暹罗芽孢杆菌(Bacillus siamensis)JFL15抗菌物质的纯化鉴定及其生物合成途径解析", 《中国博士学位论文全文数据库(工程科技I辑)》 *
许本宏: "暹罗芽孢杆菌(Bacillus siamensis)JFL15抗菌物质的纯化鉴定及其生物合成途径解析", 《中国博士学位论文全文数据库(工程科技I辑)》, no. 08, 15 August 2020 (2020-08-15), pages 024 - 19 *
陆雅琴等: "芽孢杆菌P6产抗菌脂肽条件优化及发酵液性质研究", 《中国食品学报》 *
陆雅琴等: "芽孢杆菌P6产抗菌脂肽条件优化及发酵液性质研究", 《中国食品学报》, vol. 18, no. 11, 30 November 2018 (2018-11-30), pages 90 - 96 *
高晓平等: "Surfactin抑制乳中大肠杆菌O157活性研究", 《食品科学》 *
高晓平等: "Surfactin抑制乳中大肠杆菌O157活性研究", 《食品科学》, vol. 30, no. 11, 8 July 2014 (2014-07-08), pages 91 - 94 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115109122A (en) * 2022-08-29 2022-09-27 华南农业大学 Rapid extraction method for extracting surfactin based on XAD16 macroporous resin

Also Published As

Publication number Publication date
CN112795587B (en) 2023-08-29

Similar Documents

Publication Publication Date Title
CN101429514B (en) Di-carbonyl reduction enzyme, its gene and uses thereof
EP3103873B1 (en) Biosynthesis gene cluster of streptomyces xiamenensis, use and bacterial strain
CN110951667B (en) Fenogen element high-yield strain LPB-18N and breeding and application thereof
CN113583900A (en) Burkholderia mutant strain and chassis strain with reasonably simplified genome as well as construction method and application thereof
CN114410560B (en) Engineering strain for high-yield FK228 and construction and application thereof
CN110343709B (en) Nocardiopsis arctica lasso peptide gene cluster and cloning and expression method thereof
CN114958627A (en) Construction method and application of recombinant schizochytrium limacinum engineering bacterium for high yield of tocopherol
CN112795587B (en) Escherichia coli engineering bacteria producing surfactant, construction method and application thereof
CN111117942B (en) Genetic engineering bacterium for producing lincomycin and construction method and application thereof
CN111440734B (en) Genetic engineering yeast for producing baicalein compounds, and construction method and application thereof
WO2014092345A1 (en) Fusaricidin-producing strain, and method for mass producing fusaricidin using same
CN109136253B (en) Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _5754 gene approach
CN111019948A (en) Fenjunsu anabolism regulation gene FenSr3 and application thereof
CN114934062B (en) Engineering bacterium for efficiently expressing D-psicose 3-epimerase and application
CN112961816B (en) Arthrobacter simplex engineering bacteria with steroid C1,2 dehydrogenation reaction capability
CN111197019B (en) Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _1906 gene approach
CN106554932B (en) Genencor engineering bacterium for producing gentamicin B and construction method thereof
CN111363710B (en) Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _4839 gene pathway
CN105985967B (en) Biological synthesis gene cluster of oosporins and application thereof
CN101892228B (en) Engineering bacteria with high tolerance to acrylamide and acrylonitrile for producing nitrile hydratase and application thereof
CN110540943A (en) Gene engineering strain for producing emodin and construction method and application thereof
CN110846264A (en) Genetically engineered bacterium and preparation method and application thereof
CN114875003B (en) Mutant of short-chain dehydrogenase, coding gene obtaining method and application of mutant
CN113969258B (en) Construction method of bacillus subtilis artificial strain for converting arabinose into Feng Yuan element
CN114478430B (en) Spore thiazole compounds and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant